ICON PLC at Barclays Global Healthcare Conference Transcript
Great. And thank you, everybody, for joining. This is our final presentation of the morning here on Tuesday with ICON. We have the CFO Brendan Brennan as well as IR, Jonathan Curtain, here from ICON. And I am Jack Meehan, the Barclays Life Science Tools & Diagnostics analyst.
Before we kick it off, we're going to do some audience response questions, so please use the BlackBerrys in front of you. Number one, what do you view as ICON's organic growth profile over the next 3 years?
(Voting)
And we're going to test Brendan's answers later against the audience response. Okay, so most people feed in the high-single digit, 60% of the responses, most of the rest in mid-singles. Number two, do you think organic growth will accelerate from current levels and when?
(Voting)
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
